Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
419 JPY | 0.00% | -0.95% | -40.31% |
Mar. 19 | SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March | MT |
Mar. 19 | Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform | MT |
Business Summary
Number of employees: 65
Managers
Managers | Title | Age | Since |
---|---|---|---|
Keita Mori
CEO | Chief Executive Officer | 56 | 13-02-26 |
Shinya Hirata
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Administrative Officer | - | - | |
Naoki Tsukahara
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Noboru Kotani
BRD | Director/Board Member | 67 | 13-02-28 |
Keita Mori
CEO | Chief Executive Officer | 56 | 13-02-26 |
Toru Kawanishi
CHM | Chairman | 56 | 13-02-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 68,630,002 | 48,833,077 ( 71.15 %) | 278 ( 0.000405 %) | 71.15 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
SANBIO COMPANY LIMITED 0.00% | 200 | 0.00% | 588 $ |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.31% | 183M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 4592 Stock
- Company SanBio Company Limited